Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

NSW: Anti-Wart Vaccines Set for Australian Trials




 

Australian Associated Press (08/11/99)

Australian researchers say that an experimental vaccine for human papilloma virus (HPV) has demonstrated surprising success. The vaccine uses non-infectious virus-like particles (VLPs) and generated both antibodies and a cellular immune responses. All participants in the study had an immune response to the VLPs at the end of the 12-week immunization period, and two-thirds of the women had no genital warts after treatment. The study will be published in an upcoming issue of the journal Vaccine.



 


Copyright © 1999 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.



Information in this article was accurate in August 11, 1999. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.